PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy
Yan-Pei Zhang(Nanfang Hospital), Zhong‐Yi Dong(Southern Medical University), Yuan Fang(Nanfang Hospital), Zhong Wu(Nanfang Hospital), Zi-Xuan Rong(Nanfang Hospital), Xue Bai(Southern Medical University), Jia-Le Tan(Nanfang Hospital), Qiankun Xie(Nanfang Hospital), Duan-Duan Han(Nanfang Hospital), Kexin Zhuang(Nanfang Hospital), Ze-Qin Guo(Nanfang Hospital), Lushan Xiao(Nanfang Hospital), Zipeng Xu(Nanfang Hospital), Min Ruan(Chinese Academy of Medical Sciences & Peking Union Medical College), Si-Cong Ma(Nanfang Hospital), Xiao-Ting Cai(Nanfang Hospital), Wei Wei(Guangxi Medical University), Jian Wang(Nanfang Hospital), Li Liu(Air Force Medical University), Jiaqi Chen(Guizhou University), Jianying Gu(Fudan University), Jian Guan(Southern Medical University), Yan Lin(Nanfang Hospital), Di Wu(Tongji Hospital), Dayong Zheng(Southern Medical University), Yue Chen(Nanfang Hospital), Zihang Yu(Nanfang Hospital), Yuanyuan Wang(Third Hospital of Hebei Medical University), Chuanhui Cao(Ganzhou People's Hospital), Yu Ruan(Nanfang Hospital), Yang-Si Li(Guangdong Academy of Medical Sciences), Le-Yi Lin(Nanfang Hospital), Xin-Ran Tang(Nanfang Hospital)
Cited by 30
Related Papers
CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis
|Nature Communications|2019|243
The Long Intergenic Noncoding RNA UFC1, a Target of MicroRNA 34a, Interacts With the mRNA Stabilizing Protein HuR to Increase Levels of β-Catenin in HCC Cells
|Gastroenterology|2014|231
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2020|225